Oncology Editing and Proofreading Services
Oncology documents are read in a state no editor should forget. A patient handed a treatment plan has just been told something that reorganised their life an hour ago, and they will take that paper home and read it repeatedly, looking for the sentence that tells them what happens now. Writing for that reader means deciding what belongs on page one and what can wait — a judgement most oncology material never makes.
We edit what oncology services produce — treatment plans and chemotherapy protocol documentation, informed consent for systemic therapy, radiotherapy, and trials, patient education on regimens, side effects, and when to call, tumour board and multidisciplinary meeting records, staging and response assessment reporting, clinical trial protocols, consent forms, and patient information sheets, prior-authorisation letters for high-cost agents, survivorship and follow-up care plans, palliative and goals-of-care discussions, and manuscripts for oncology journals. Our editors verify that regimen names, cycle numbering, and dosing conventions are consistent, and that consent describes benefit in terms the patient can weigh.
The document that saves lives here is the side-effect and call-us instruction. Neutropenic sepsis kills people who waited until morning because the leaflet said to contact the team "if you feel unwell". We rewrite that material so the threshold is a number and the instruction is unambiguous — this temperature, this symptom, this phone number, at any hour, do not wait — and we put it where an exhausted person finds it in seconds rather than on page nine.
Everything you send is treated with strict confidentiality, including trial material under embargo. Whether you are writing patient information for a regimen that frightens people, a consent form that has to be honest about modest benefit, or a manuscript in English as an additional language, we can make the writing clear without making it cold.
Key Oncology vocabulary
- Histological diagnosis
- TNM staging
- Grade
- Performance status
- Multidisciplinary tumour board
- Systemic therapy
- Cytotoxic chemotherapy
- Targeted therapy
- Immunotherapy
- Immune-related adverse event
- Hormone therapy
- Radiotherapy fractionation
- Neoadjuvant therapy
- Adjuvant therapy
- Palliative intent
- Curative intent
- Treatment cycle
- Dose intensity
- Dose reduction
- Body surface area dosing
- Febrile neutropenia
- Neutropenic sepsis
- Antiemetic protocol
- Response assessment
- RECIST criteria
- Progression-free survival
- Overall survival
- Clinical trial protocol
- Survivorship care plan
- Goals of care
- Prior authorisation
Oncology Word Challenge
Even seasoned pros miss these — give it a shot.
« More Healthcare and Medicine editing | All editing services